Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|June 1, 2005
- Volume 0 0
PhRMA Revamps Web Site
Advertisement
The Pharmaceutical Research andManufacturers of America (PhRMA)'sWeb site has undergone improvements.The site (www.innovation.org)tells the story of biopharmaceuticaldiscovery and shares patient storiesand research findings on the impact ofnew drugs. The content-driven andinteractive Web site includes the following:
- Video presentations on key phasesof biopharmaceutical research
- New information for patients andpolicy makers on health, disease,and medicines recently approvedand in development
- An interactive time line highlightingsignificant discoveriesover the past century
- An e-newsletter, "InnovationsInsights."
Articles in this issue
over 21 years ago
Consensus Guidelines for Hormone Therapyover 21 years ago
OTC Therapies for Allergic Rhinitisover 21 years ago
A Pharmacist's Guide to OTC Therapy: Menstrual Pain Productsover 21 years ago
A Pharmacist's Guide to OTC Therapy: Calcium Supplementsover 21 years ago
RxPRODUCT NEWS: PROFILE: Boniva (ibandronate)over 21 years ago
Ovulation-Prediction Testing Kits: A Woman's Choiceover 21 years ago
Examining Antithrombotic Therapyover 21 years ago
Web Site Expands Servicesover 21 years ago
RADAR Detects Drug ReactionsAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
4
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
5